ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

ME Staff 8-k

7 years ago

ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

EXHIBIT INDEX

ExhibitNo.	Description
10.1	Offer Letter, dated as of December 18, 2017, by and between Zimmer Biomet Holdings, Inc. and Bryan C. Hanson
10.2	Change in Control Severance Agreement, dated as of December19, 2017, by and between Zimmer Biomet Holdings, Inc. and Bryan C. Hanson
10.3	Chief Executive Officer Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement, dated as of December18, 2017, by and between Zimmer Biomet Holdings, Inc. and Bryan C. Hanson
10.4	Form of NQSO Award Agreement (CEO one-time award)
10.5	Form of PRSU Award Agreement (CEO one-time award)
10.6	Form of RSU Award Agreement (CEO one-time award)
99.1	Press release issued by Zimmer Biomet Holdings, Inc., dated December19, 2017

ZIMMER BIOMET HOLDINGS, INC. ExhibitEX-10.1 2 d520208dex101.htm EX-10.1 EX-10.1 Exhibit 10.1 Confidential December 18,…To view the full exhibit click here
About ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH)
Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc., is engaged designing, manufacturing and marketing orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company’s products and solutions helps treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consists of the United States and includes other North, Central and South American markets; EMEA, consists of Europe and includes the Middle East and African markets, and Asia Pacific, consists of Japan and includes other Asian and Pacific markets. Its four product category segments include Americas Spine, Bone Healing Craniomaxillofacial and Thoracic, and Dental.